FeesSafety
Pluang+

Hyperliquid's perpetual futures open interest hits record $18.1B, boosting market share to 11.7% by Q3 end.

Technical Signals
13 Nov 2026, 11:29 WIB
Tokenpost
View Source
Bullish
Hyperliquid's perpetual futures open interest hits record $18.1B, boosting market share to 11.7% by Q3 end.

Hyperliquid's perpetual futures open interest reached a record $18.1 billion on September 22, with its share of combined open interest across the platform and eight centralized exchanges rising to 11.7% by the end of Q3. The average open interest for the quarter was $12.7 billion, up 46.4% from Q2, indicating growing trader engagement. Matched trading volume totaled $730.6 billion in Q3, a 9.3% increase from the previous quarter, while daily traders rose 20% to an average of 65,161. This growth highlights Hyperliquid's expanding influence in the digital asset futures market amid fluctuating volumes across different asset classes.

Hyperliquid's open interest and trading activity provide context for digital asset futures markets. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Nov 13, 2026 16:02 WIB: Among 50 major cryptocurrencies priced on Pluang, 13 rose and 36 fell today. Notable movers include Bitcoin Cash (BCH) at Rp4.007.790 with a 1-day change of -3.37% and a Pluang order activity of 25% Sell / 75% Buy, Avalanche (AVAX) at Rp151.026 with -3.36% and 35% Sell / 65% Buy, and Filecoin (FIL) at Rp13.252 with -3.34% and 95% Sell / 5% Buy. The most notable figure is BCH's typical hold time on Pluang of 69 days.

More News

China Eastern Airlines signs $540M procurement deals, unveils new aviation tech at CIIE

China Eastern Airlines signs $540M procurement deals, unveils new aviation tech at CIIE

China Eastern Airlines signed 23 procurement agreements worth $540 million with 15 suppliers from eight countries at the 9th China International Import Expo in Shanghai. The deals cover aircraft engines, aviation materials, jet fuel, and in-flight ca...

Bullish
1 hour ago
PAS-004 shows strong reductions in neurofibroma size with good safety, advancing to Phase 2 trials after FDA clearance.

PAS-004 shows strong reductions in neurofibroma size with good safety, advancing to Phase 2 trials after FDA clearance.

Pasithea Therapeutics announced positive Phase 1/1b results for PAS-004, showing significant reductions in cutaneous neurofibromas (cNF) size by up to 71% with continued treatment and early activity in plexiform neurofibromas (PN). The drug demonstra...

Company Fundamentals
Bullish
3 hours ago
Eramet launches €500M share capital increase with preferential subscription rights to reduce debt.

Eramet launches €500M share capital increase with preferential subscription rights to reduce debt.

Eramet announced a €500 million share capital increase through a rights issue, offering 6 new shares for every 5 existing shares at €14.49 each. The proceeds will be used to reduce the company's debt and strengthen its balance sheet as part of a prev...

Company Fundamentals
Neutral
3 hours ago
Shandong-South Korea Economic Conference opens with 23 new cooperation projects signed in Yantai.

Shandong-South Korea Economic Conference opens with 23 new cooperation projects signed in Yantai.

The 9th Shandong-South Korea Economic and Trade Cooperation Conference and Yantai South Korea Week began on November 6 in Yantai, Shandong Province, highlighting strong economic ties between Shandong and South Korea. Over 150 enterprises participated...

Bullish
4 hours ago
Bitcoin dips below $68,000 amid $1.5B crypto liquidations and ETF outflows, facing risk of further decline to $65,000.

Bitcoin dips below $68,000 amid $1.5B crypto liquidations and ETF outflows, facing risk of further decline to $65,000.

Bitcoin briefly fell below $68,000 on November 13, driven by accelerated selling and leveraged liquidations nearing $1.5 billion, mainly from long positions. Institutional demand weakened as Bitcoin ETFs saw nearly $1.5 billion in net outflows over a...

Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App